Screening for Bipolar Disorder in Patients Treated for Depression in a Family Medicine Clinic

References

1. ↵
   Manning JS, Haykal RF, Connor PD, Akiskal HS. On the nature of depressive and anxious states in a family practice setting: the high prevalence of bipolar II and related disorders in a cohort followed longitudinally. Compr Psychiatry 1997; 38: 102–8.

   OpenUrlCrossRefPubMedWeb of Science
2. ↵
   Hantouche EG, Akiskal HS, Lancrenon S, et al. Systematic clinical methodology for validating bipolar-II disorder: data in mid-stream from a French national multi-site study (EPIDEP). J Affect Disord 1998; 50: 163–73.

   OpenUrlCrossRefPubMedWeb of Science
3. ↵
   Benazzi F. Prevalence of bipolar II disorder in outpatient depression: a 203-case study in private practice. J Affect Disord 1997; 43: 163–6.

   OpenUrlCrossRefPubMedWeb of Science
4. ↵
   Angst J. The emerging epidemiology of hypomania and bipolar II disorder. J Affect Disord 1998; 50: 143–51.

   OpenUrlCrossRefPubMedWeb of Science
5. ↵
   Hirschfeld RMA, Vornik LA. Course and treatment of bipolar depression. In: Bowden CL, editor. Diagnosis and management of bipolar disorders. London (UK): Science Press; 2004. p. 28–40.
6. ↵
   American Psychiatric Association. Diagnostic and statistical manual of mental disorders (DSM-IV), 4th ed. Washington (DC): American Psychiatric Association; 1994.
7. ↵
   Hirschfeld RMA, Williams JB, Spitzer RL, et al. Development and validation of a screening instrument for bipolar spectrum disorder: the Mood Disorder Questionnaire. Am J Psychiatry 2000; 157: 1873–5.

   OpenUrlCrossRefPubMedWeb of Science
8. ↵
   Hirschfeld RMA, Holzer C, Calabrese JR, et al. Validity of the Mood Disorder Questionnaire: a general population study. Am J Psychiatry 2003; 160: 178–80.

   OpenUrlCrossRefPubMedWeb of Science
9. ↵
   First MB, Spitzer RL, Gibbon M, Williams JBW. Structured clinical interview for DSM-IV Axis I disorders, patient edition. SCID-I/P, Version 2.0. New York: New York State Psychiatric Institute, Biometrics Research; 1994.
10. ↵
    Spitzer RL, Williams JB, Gibbon M, First MB. The structured clinical interview for DSM-III-R (SCID). I: History, rationale, and description. Arch Gen Psychiatry 1992; 49: 624–9.

    OpenUrlCrossRefPubMedWeb of Science
11. ↵
    Williams JB, Gibbon M, First MB, et al. The structured clinical interview for DSM-III-R (SCID). II. Multisite test-retest reliability. Arch Gen Psychiatry 1992; 49: 630–6.

    OpenUrlCrossRefPubMedWeb of Science
12. ↵
    Cantor SB, Katten MW. Determining the area under the curve for a binary diagnostic test. Med Decic Making 2001; 20: 468–70.

    OpenUrl
13. ↵
    Hirschfeld RMA. The Mood Disorder Questionnaire: a simple, patient-rated screening instrument for bipolar disorder. Prim Care Companion J Clin Psychiatry 2002; 4: 9–11.

    OpenUrlPubMed
14. ↵
    Ghaemi SN, Rosenquist KJ, Ko JY, Baldassano CF, Kontos NJ, Baldessarini RJ. Antidepressant treatment in bipolar versus unipolar depression. Am J Psychiatry 2004; 161: 163–5.

    OpenUrlCrossRefPubMed
15. ↵
    Ghaemi SN, Hsu DJ, Soldani F, Goodwin FK. Antidepressants in bipolar disorder: the case for caution. Bipolar Disord 2003; 5: 421–33.

    OpenUrlCrossRefPubMedWeb of Science